{"name":"Nalagenetics Pte Ltd","slug":"nalagenetics-pte-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE11U29fT0lidFFfWmh3NEk1Y1dWa192S1V3Y3JZZVhmWjlkOE5ZbWxCUWtlMkN5WkxVUDBmbHpMM2hxcTd6SThOWExZeGRFYTdpWWktYTYzOXJ6UE01YWVCQ0VZU25KZXVfR1JiNjVTVE9aeDdRZGVXZDN5TQ?oc=5","date":"2025-05-07","type":"pipeline","source":"medrxiv.org","summary":"Targeted adaptive sampling enables clinical pharmacogenomics testing and genome-wide genotyping - medrxiv.org","headline":"Targeted adaptive sampling enables clinical pharmacogenomics testing and genome-wide genotyping","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5BT2hTb08wVFBMcHR1WGpYUl9kTGdRbnFLbFB3WElSSWJDclNfOGVSeUJuV2lVOFAzQzNwSXBuVm0zT0NSX3BLSWdkRFRZb2hjWW1obXA1NmZaZTdEWEw5LWxnYXZCeEJpZnM4ZURCbDQ0NlVwbUVfTkVEMA?oc=5","date":"2024-07-19","type":"trial","source":"medrxiv.org","summary":"Implementation of Pre-emptive Pharmacogenomics Testing in Outpatient Clinics in Asia (IMPT study) - medrxiv.org","headline":"Implementation of Pre-emptive Pharmacogenomics Testing in Outpatient Clinics in Asia (IMPT study)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}